Skip to main navigation

Investors & Media
Contact Us
Linkedin
Twitter

Overview
News & Events
- Press Releases
- Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
Investors + Media
Medical Professionals
Contact Us
Linkedin
Twitter

Press Releases

Items Per Page

Year

04 Jan 2022

SpringWorks Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

PDF Version

10 Dec 2021

SpringWorks Therapeutics Announces Clinical Collaboration with AbbVie to Evaluate Nirogacestat in Combination with ABBV-383 in Patients with Relapsed or Refractory Multiple Myeloma

PDF Version

06 Dec 2021

SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b/2 Trial Evaluating Nirogacestat in Combination with Elranatamab (PF-06863135) in Patients with Relapsed or Refractory Multiple Myeloma

PDF Version

29 Nov 2021

SpringWorks Therapeutics Announces Full Enrollment of Phase 2b ReNeu Trial Evaluating Mirdametinib in Adult and Pediatric Patients with NF1-Associated Plexiform Neurofibromas

PDF Version

23 Nov 2021

SpringWorks Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference

PDF Version

04 Nov 2021

SpringWorks Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights

PDF Version

27 Oct 2021

SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and Addition of New Sub-Studies to Existing Clinical Collaboration with GlaxoSmithKline Evaluating Nirogacestat in Combination with BLENREP in Patients with Relapsed or Refractory Multiple Myeloma

PDF Version

20 Oct 2021

SpringWorks Therapeutics to Collaborate with Ab Magnitude on Target Identification and Discovery of Next-Generation Targeted Oncology Therapeutics

PDF Version

20 Oct 2021

SpringWorks Therapeutics to Collaborate with Leading Academic Institutions to Advance Portfolio of Next-Generation Mutation-Selective EGFR Inhibitors

PDF Version

07 Sep 2021

SpringWorks Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

Displaying 1 - 10 of 85

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds
Investor Contacts

Request E-mail Alerts

Social Links

Who We Are
Focus Areas

Pipeline
Careers
- View Opportunities

Patients
Contact

Investors & Media

© 2022 SpringWorks Therapeutics. All rights reserved.

Copyright Links

Privacy Policy
Terms of Use